EphA2 Gene Targeting Using Neutral Liposomal Small Interfering RNA Delivery

This study is not yet open for participant recruitment.
Verified May 2013 by M.D. Anderson Cancer Center
Sponsor:
Collaborator:
Ovarian Cancer Research Fund
Information provided by (Responsible Party):
M.D. Anderson Cancer Center
ClinicalTrials.gov Identifier:
NCT01591356
First received: May 2, 2012
Last updated: May 6, 2013
Last verified: May 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: September 2018 (Final data collection date for primary outcome measure)